Literature DB >> 15271427

Inflammatory stromal keratopathies: medical management of stromal keratomalacia, stromal abscesses, eosinophilic keratitis, and band keratopathy in the horse.

Dennis E Brooks1.   

Abstract

This article discusses the diagnosis and medical treatment of stromal keratomalacia or "melting ulcers," stromal abscesses, eosinophilic keratitis (EK), and calcific band keratopathy. These are common and important inflammatory keratopathies of the equine corneal stroma. Keratomalacia and stromal abscesses are associated with infection, leukocytic invasion of the stroma, and loss of tissue and tear film proteinase homeostasis. Eosinophils infiltrate the stroma in response to unknown stimuli in EK. Calcium is deposited in the stroma and epithelium secondary to chronic equine recurrent uveitis in calcific band keratopathy. They are all associated with varying degrees of iridocyclitis.

Entities:  

Mesh:

Year:  2004        PMID: 15271427     DOI: 10.1016/j.cveq.2004.04.007

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  4 in total

1.  Diagnostic ophthalmology.

Authors:  Lynne S Sandmeyer; Bianca S Bauer; Bruce H Grahn
Journal:  Can Vet J       Date:  2014-01       Impact factor: 1.008

2.  Equine infectious keratitis in Finland: Associated microbial isolates and susceptibility profiles.

Authors:  Minna P Mustikka; Thomas S C Grönthal; Elina M Pietilä
Journal:  Vet Ophthalmol       Date:  2019-07-31       Impact factor: 1.644

3.  Equine Umbilical Cord Serum Composition and Its Healing Effects in Equine Corneal Ulceration.

Authors:  Xavier Peyrecave-Capo; Nathalie Saulnier; Stéphane Maddens; Bérengère Gremillet; Isabelle Desjardins
Journal:  Front Vet Sci       Date:  2022-03-17

4.  The prevalence of ocular diseases in polish Arabian horses.

Authors:  Katarzyna Paschalis-Trela; Anna Cywińska; Jan Trela; Michał Czopowicz; Jerzy Kita; Lucjan Witkowski
Journal:  BMC Vet Res       Date:  2017-11-07       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.